Bumrungrad Hospital Public Company Limited (BZ7A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bumrungrad Hospital Public Company Limited (BZ7A) has a cash flow conversion efficiency ratio of 0.035x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€981.59 Million ≈ $1.15 Billion USD) by net assets (€27.71 Billion ≈ $32.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bumrungrad Hospital Public Company Limit (BZ7A) market capitalisation for the company's overall valuation and market capitalisation.
Bumrungrad Hospital Public Company Limited - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Bumrungrad Hospital Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bumrungrad Hospital Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bumrungrad Hospital Public Company Limited ranked by their cash flow conversion efficiency. Explore BZ7A cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fadel Partners Inc
LSE:FADL
|
N/A |
|
Europlasma SA
PA:ALEUP
|
0.657x |
|
World Chess PLC
LSE:CHSS
|
0.034x |
|
Serinus Energy
LSE:SENX
|
0.002x |
|
Mercantile Ports & Logistics Ltd
LSE:MPL
|
-0.010x |
|
Mothercare PLC
LSE:MTC
|
0.109x |
|
RC365 Holding PLC
LSE:RCGH
|
-4.061x |
|
Philipp Holzmann AG
DU:HOZ
|
N/A |
Annual Cash Flow Conversion Efficiency for Bumrungrad Hospital Public Company Limited (2016–2025)
The table below shows the annual cash flow conversion efficiency of Bumrungrad Hospital Public Company Limited from 2016 to 2025. View BZ7A live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €31.17 Billion ≈ $36.44 Billion |
€8.25 Billion ≈ $9.65 Billion |
0.265x | -15.11% |
| 2024-12-31 | €27.80 Billion ≈ $32.50 Billion |
€8.67 Billion ≈ $10.14 Billion |
0.312x | +2.39% |
| 2023-12-31 | €24.10 Billion ≈ $28.17 Billion |
€7.34 Billion ≈ $8.58 Billion |
0.305x | -1.91% |
| 2022-12-31 | €20.01 Billion ≈ $23.39 Billion |
€6.21 Billion ≈ $7.26 Billion |
0.311x | +53.85% |
| 2021-12-31 | €17.62 Billion ≈ $20.60 Billion |
€3.56 Billion ≈ $4.16 Billion |
0.202x | +68.20% |
| 2020-12-31 | €18.84 Billion ≈ $22.02 Billion |
€2.26 Billion ≈ $2.64 Billion |
0.120x | -50.34% |
| 2019-12-31 | €20.27 Billion ≈ $23.69 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.242x | -4.31% |
| 2018-12-31 | €18.74 Billion ≈ $21.91 Billion |
€4.73 Billion ≈ $5.53 Billion |
0.253x | -19.54% |
| 2017-12-31 | €16.70 Billion ≈ $19.53 Billion |
€5.24 Billion ≈ $6.13 Billion |
0.314x | -10.28% |
| 2016-12-31 | €14.79 Billion ≈ $17.29 Billion |
€5.17 Billion ≈ $6.05 Billion |
0.350x | -- |
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic,… Read more